Wonder Drug? The GLP-1 Story
A gut hormone that, on its own, does almost nothing became the most talked-about medicine of the decade. Wonder Drug? follows the GLP-1 drugs — Ozempic, Wegovy, Mounjaro, Zepbound, and the next generation — from a 1980s discovery and a lizard's venom to a class now taken by roughly one in eight American adults. Six evenhanded, hype-skeptical episodes ask a stubborn question: are these actually a magic bullet for a long list of seemingly unrelated conditions, or is adoption outrunning the evidence? Carefully sourced; narrated by AI from human-reviewed research.
Listen on Apple Podcasts, Spotify, YouTube, or paste the RSS link into any podcast app.
Episodes
6. Magic Bullet?
The verdict.
5. The Great American Experiment
One in eight adults, the off-label frontier, the telehealth-and-compounding gray market, the price war (TrumpRx, Medicare, generics), and a pipeline testing one molecule against nearly everything..
4. The Mind on GLP-1
A striking real-world dementia signal meets a wall of failed Alzheimer's and Parkinson's trials.
3. Beyond the Waistline
Why a weight-loss drug protects the heart, kidney, and liver — often whether or not you lose weight (SELECT, FLOW, ESSENCE, SURMOUNT-OSA) — and inflammation as the possible unifying thread.
2. The Family of Molecules
GLP-1 vs GLP-2 vs "GLP-3." The real drug family drawn from a single gene — semaglutide, tirzepatide, and the next generation — and why GLP-2 is real while GLP-3 simply does not exist..
1. The Accidental Blockbuster
How a gut hormone that does almost nothing on its own became medicine's "everything drug" — from an anglerfish and a Gila monster's venom to the chemistry that made Ozempic.